PDCD1 and neoplasm: It was proposed that OXPHOS produces a rapid increase in mitochondrially derived reactive oxygen species (ROS)15, which stimulate the proliferation of T cells that can be reinvigorated by disrupting the PD-1–PD-L1 axis upon anti-PD-1 blockade, thereby improving tumor killing16.